Back

Circulating biomarkers are associated with atrial fibrillation burden in patients with paroxysmal atrial fibrillation

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation pathophysiology and mechanisms Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Maria Hee Jung Park Frausing

Aarhus University Hospital, Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail
The impact of atrial dilatation on conduction heterogeneity at bachmann's bundle
Ms A. Freriks (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation
Doctor P. Lustig (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Relative blood pressure increase is associated with subsequent atrial fibrillation episodes in long-term out-patient monitoring: TriggersAF
Doctor J. Bacevicius (Vilnius, LT)
Abstract Slides Video
Presentation thumbnail
Interdependence of local cycle length, duty cycle, spatiotemporal consistency, and bipolar voltage in the atrial fibrillation substrate
Professor A. Luik (Karlsruhe, DE)
Abstract Slides Video
Presentation thumbnail
Unipolar potential voltage mapping of bachmann's bundle during different stages of atrial fibrillation: a novel target for ablation therapy?
Ms A. Freriks (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation pathophysiology and mechanisms

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Association of atrial fibrillation burden and clinical profile with blood biomarkers: results from the ISOLATION ablation cohort.
thumbnail
Congress Presentation
Clinical determinants of blood biomarkers of atrial cardiomyopathy: results from the ISOLATION AF ablation cohort study.
thumbnail
Congress Presentation
The association of NT-proBNP levels in atrial fibrillation patients and 3-year risk of heart hospitalization and death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources